Enlivex Therapeutics Ltd. Quarterly Costs and Expenses in USD from Q1 2021 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Enlivex Therapeutics Ltd. quarterly/annual Costs and Expenses history and growth rate from Q1 2021 to Q2 2022.
  • Enlivex Therapeutics Ltd. Costs and Expenses for the quarter ending May 31, 2022 was $1M.
Costs and Expenses, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $1M May 31, 2022 20-F 2024-04-30
Q1 2021 $126K Feb 28, 2021 20-F 2024-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.